Related Experiment Videos
Treatment approaches for acute mania
J C Chou1, I Tuma, E A Sweeney
1Nathan S. Kline Institute, Orangeburg, NY 10962.
The Psychiatric Quarterly
|January 1, 1993
Summary
This study reviews drug treatments for mania, highlighting mood stabilizers like carbamazepine and valproic acid as alternatives to lithium. It also advises minimizing neuroleptic use and considering benzodiazepines for acute mania management.
Area of Science:
- Psychopharmacology
- Neuroscience
- Clinical Psychiatry
Background:
- Mania treatment involves mood stabilizers and tranquilizers.
- Current treatment guidelines require refinement, particularly regarding lithium-refractory patients.
- Existing literature lacks clear definitions for lithium-refractoriness.
Purpose of the Study:
- To define indications for mood stabilizers and tranquilizers in mania treatment.
- To present a decision tree for acute mania management.
- To provide guidelines for selecting and combining mood-stabilizing agents.
Main Methods:
- Conceptual division of mania drugs into mood stabilizers and tranquilizers.
- Presentation of a graphical decision tree for acute mania treatment.
- Review of anticonvulsants (carbamazepine, valproic acid) and their efficacy compared to lithium.
- Discussion on the use and dosing of neuroleptics and benzodiazepines.
Main Results:
- Carbamazepine and valproic acid show efficacy comparable to lithium, effective in lithium-refractory cases, but require more study for maintenance.
- Neuroleptic use in mania should be minimized due to side effect risks (e.g., tardive dyskinesia).
- Benzodiazepines can serve as alternatives or adjuncts to lower neuroleptic doses in non-substance-abusing patients.
Conclusions:
- Mood stabilizers, including newer anticonvulsants, offer effective mania treatment options.
- Optimizing tranquilizer use, particularly neuroleptics, is crucial to mitigate side effects.
- Further research is needed to define lithium-refractoriness and evaluate long-term maintenance strategies.